Medtronic today announced that it received National Medical Products Administration approval in China for its CoreValve Evolut Pro TAVR system. The approval marks the first Medtronic TAVR system approved in China for patients with symptomatic severe aortic stenosis who are at high or extreme risk for open-heart surgery, according to the company. Medtronic’s approval of […]
tavr
Abbott sees the delivery system as a differentiator for its TAVR
A top Abbott executive explains how the company’s FlexNav delivery system could make the Portico TAVR competitive. Abbott is aiming to claw away market share from transcatheter aortic valve replacement pioneers Edwards Lifesciences and Medtronic. The Abbott Park, Illinois–based medtech company in September announced FDA approval of its Portico with FlexNav TAVR system, more than […]
FDA approves Edwards Lifesciences Sapien 3 with Alterra for pulmonary regurgitation
Edwards Lifesciences (NYSE:EW) announced today that it received FDA approval for the use of its Sapien 3 transcatheter valve with the Alterra adaptive prestent. Irvine, California-based Edwards garnered the FDA nod for use of the Sapien 3 with Alterra for patients with severe pulmonary regurgitation. The Sapien 3 transcatheter pulmonary valve (TPV) system combines the […]
Sapien 3 TAVR offers improved outcomes, reduced cost, Edwards Lifesciences says
Edwards Lifesciences (NYSE:EW) today touted a cost-effectiveness analysis that supports transcatheter aortic valve replacement (TAVR) with the Sapien 3. Irvine, California-based Edwards presented data from the Partner 3 trial during the late-breaking clinical trials at the 33rd Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation. According to a news release, […]
Medtronic touts 5-year study of self-expanding TAVR platform
Medtronic (NYSE:MDT) today presented five-year clinical data for its CoreValve and Evolut transcatheter aortic valve implantation (TAVI) platforms. Fridley, Minnesota-based Medtronic presented results from the Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI) trial at the 33rd Transcatheter Cardiovascular Therapeutics (TCT) conference. According to a news release, data from the trial demonstrated that the hemodynamic […]
Abbott enters U.S. TAVR market with FDA approval of its Portico with FlexNav
Abbott (NYSE:ABT) today announced U.S. FDA approval of its Portico with FlexNav TAVR system. The approval launches Abbott into a U.S. TAVR space that Edwards Lifesciences and Medtronic have dominated. (Check out our recent DeviceTalks Weekly podcast that recounted Edwards Lifesciences’ pioneering work in the space.) Boston Scientific is out of the TAVR market for […]
Evolut TAVR just as good as open-heart surgery among younger people, Medtronic says
Medtronic (NYSE:MDT) today touted two-year outcomes for a trial comparing its Evolut TAVR system to open-heart surgery in younger people. Fridley, Minn.-based Medtronic’s Evolut transcatheter aortic valve replacement (TAVR) system went up against the gold standard of open-heart surgery in younger, healthier aortic stenosis patients in the trial, which had its results presented as a […]
Boston Sci among UBS analysts’ top stock picks for 2021
UBS Investment Bank listed Boston Scientific (NYSE:BSX) among its 21 most compelling stock investment selections for 2021. Marlborough, Mass.-based Boston Scientific was the only medical device company on a list that featured companies such as Amazon, Morgan Stanley and Southwest Airlines. Additionally, Vertex Pharmaceuticals represented the biotech space, while Acadia Healthcare registered for healthcare facilities. UBS […]
Edwards Lifesciences projects TAVR, overall growth in 2021
Edwards Lifesciences (NYSE:EW) is projecting significant growth for 2021, particularly in its transcatheter aortic valve replacement business. Irvine, Calif.-based Edwards is projecting 2021 TAVR sales to represent growth of between 15% and 20% as well as growth in the mid-teens for global sales, the company shared during its investor day presentation. Additionally, Edwards projected adjusted earnings […]
Boston Scientific CEO Mike Mahoney talks Lotus decision, post-COVID outlook
Boston Scientific (NYSE:BSX) made waves this month when it recalled and retired its Lotus TAVR product line. Subsequent layoffs, first in Minnesota, then in Ireland, highlighted the impact of the decision to pull Lotus from the highly competitive market as a result of complexities related to the product delivery system and solely that — as the […]
Boston Scientific’s Lotus layoffs extend to Ireland
Boston Scientific (NYSE:BSX) has reportedly confirmed job losses at its Galway, Ireland, location, following the retirement of the Lotus Edge. Galway Bay FM reported today that the Marlborough, Mass.-based company confirmed the job losses at its Ireland location, adding that Boston Scientific confirmed the job loss will affect fewer than 30 employees. The report said that […]